GSK plc (LON:GSK) Receives Average Rating of “Moderate Buy” from Analysts

GSK plc (LON:GSK) has earned a consensus rating of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is GBX 1,842.50 ($24.11).

Several brokerages recently weighed in on GSK. Jefferies Financial Group restated a “buy” rating and issued a GBX 2,100 ($27.48) price objective on shares of GSK in a report on Thursday, June 27th. Shore Capital reaffirmed a “buy” rating on shares of GSK in a research note on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,850 ($24.21) target price on shares of GSK in a research note on Tuesday, September 3rd. JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of GSK in a research note on Monday, July 29th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 1,820 ($23.82) price objective on shares of GSK in a research note on Tuesday, September 10th.

GSK Stock Performance

Shares of LON:GSK opened at GBX 1,480 ($19.37) on Friday. The company has a current ratio of 0.82, a quick ratio of 0.73 and a debt-to-equity ratio of 123.04. GSK has a 1-year low of GBX 1,371.40 ($17.95) and a 1-year high of GBX 1,823.50 ($23.86). The stock has a market capitalization of £60.38 billion, a P/E ratio of 1,309.73, a P/E/G ratio of 1.24 and a beta of 0.31. The business has a 50-day moving average price of GBX 1,575.22 and a two-hundred day moving average price of GBX 1,613.67.

GSK Announces Dividend

The business also recently declared a dividend, which was paid on Thursday, October 10th. Shareholders of record on Thursday, August 15th were paid a GBX 15 ($0.20) dividend. This represents a yield of 0.97%. The ex-dividend date was Thursday, August 15th. GSK’s payout ratio is currently 5,309.73%.

Insider Transactions at GSK

In other news, insider Elizabeth (Liz) McKee Anderson bought 446 shares of the company’s stock in a transaction that occurred on Monday, September 23rd. The shares were acquired at an average price of GBX 2,051 ($26.84) per share, with a total value of £9,147.46 ($11,971.55). 1.61% of the stock is owned by insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.